Instructions for Authors
The Clinical Journal of Sport Medicine is an international, refereed journal published for clinicians with a primary interest in the practice of sport medicine. The Journal publishes original research and reviews covering diagnostics, therapeutics, and rehabilitation in healthy and physically challenged individuals of all ages and levels of sport and exercise participation. All manuscripts must be submitted on-line at http://cjsm.edmgr.com/. See submission instructions under "On-line manuscript submission".
ETHICAL / LEGAL CONSIDERATIONS
A submitted manuscript must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the journal, its editors, or the publisher.
Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.
Conflicts of interest and Copyright Transfer
Authors must state all possible conflicts of interest in the Title Page of the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the Title Page of the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading “Conflicts of Interest and Source of Funding:”.
Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker’s bureau for Organization X – the CME organizers for Company A. For the remaining authors none were declared.
In addition, each author must complete and submit the journal’s copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the International Committee of Medical Journal Editors, “Uniform Requirements for Manuscripts Submitted to Biomedical Journals.”
- Each author must download the form in PDF format, complete the form electronically and provide to the lead author for submission to the CJSM Editorial Manager site.
- All author forms must be completed by the time of original manuscript submission.
- Each author will be expected to complete and sign the copyright transfer agreement form electronically. For help or more information about electronically signing this form, visit our online FAQs.
Compliance with NIH and Other Research Funding Agency Accessibility Requirements: A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism.
Permissions: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material, not the responsibility of Lippincott Williams & Wilkins.
ONLINE MANUSCRIPT SUBMISSION
All manuscripts must be submitted on-line through the new Web site at http://cjsm.edmgr.com/. First-time users: Please click the Register button from the main menu and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference. Note: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, you do not have to re-register, even if your status changes (that is, author, reviewer, or editor). Authors: Please click the log-in button from the menu at the top of the page and log in to the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact the Editorial Office e-mail:email@example.com, phone: 403-220-8947, fax: 403-210-9393. Requests for help and other questions will be addressed in the order received.
PREPARATION OF MANUSCRIPT
Original manuscripts, i.e., those that have not been published elsewhere except in abstract form, will be accepted in English language from all countries and subject to peer review by the Editors and Editorial Board. The Clinical Journal of Sport Medicine invites articles for submission from the areas of: 1) diagnosis, treatment, and rehabilitation of sport and sport-related injuries, 2) medical illnesses induced by or exacerbated by exercise, 3) the relationship between exercise and health, and the exercise prescription, and 4) the medical care of physically active individuals.
Articles are invited from the following categories: Original Research: clinical research and basic science articles that are clinically relevant; Brief Reports: clinical studies that are preliminary or limited in scope but with important findings to report; Case Reports: Reports of clinical observations that have been carefully documented and are particularly instructive.
Additional manuscripts may be submitted, after consulting with the Editor-in-Chief, in the following categories: Practical Management Manuscripts: focused, treatment-oriented reports from the perspective of the expert clinician; Lead Editorials: short syntheses of data and current thought on topical issues in the field of sport medicine; Critical Reviews: concise, in-depth, and well referenced articles that use the principles of critical appraisal (evidence-based medicine); Position Statements: succinct but comprehensive documents typically prepared by a recognized society for the purpose of providing clinical guidelines in important areas of sport medicine.
Each type of manuscript has different submission requirements in terms of style, length and format. Please review specific submission category sections for detailed submission information. Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
- Original Research
- Brief Reports
- Case Reports
- Practical Management
- Lead Editorials
- Critical Reviews
- General Reviews
- Position Statements
- Letters to the Editor
IMPORTANT NOTE: In studies that report an intervention, authors are requested, in addition to the description contained in the article, to provide an appendix as Supplemental Digital Content (SDC) that details the intervention protocol such that it could be accurately replicated. For example for an exercise regimen, give a clear description of each exercise with diagrams, photos, or video, giving number of repetitions, intensity, time allocated, and duration. (See instructions below for submitting Supplemental Digital Content and for a list of all available file types and detailed instructions, please visit http://links.lww.com/A142).
INSTRUCTIONS FOR STRUCTURED ABSTRACTS
Articles containing original data concerning the course (prognosis), cause (etiology), diagnosis, treatment, prevention, or economic analysis of a clinical disorder or an intervention to improve the quality of health care must include a structured abstract of no longer than 250 words. The structured abstract should appear on the page following the title page, using the following headings and information.
Objective: State the main question or objective of the study and the major hypothesis tested, if any.
Design: Describe the design of the study, indicating, as appropriate, use of randomization, blinding, criterion standards for diagnostic tests, temporal direction (retrospective or prospective), and so on.
Setting: Indicate the study setting, including the level of clinical care (e.g., primary or tertiary, private practice or institutional).
Patients (or Participants): State selection procedures, entry criteria, and numbers of participants entering and finishing the study.
Interventions (or Assessment of Risk Factors): Describe essential features of any interventions, including their method and duration of administration. For observational studies, clearly outline the independent variables.
Main Outcome Measurements: The primary study outcome measures (dependent variables) should be indicated as planned before data collection began. If the hypothesis being reported was formulated during or after data collection, this fact should be clearly stated.
Results: Report the main findings of the study.
Conclusions: State only those conclusions of the study that are directly supported by data, along with their clinical application (avoiding overgeneralization) or whether additional study is required before the information should be used in usual clinical settings.
Please note: Equal emphasis must be given to positive and negative findings of equal scientific merit.
Up to six key words should be included at the end of the structured abstract. In the case of research studies, a single statement summarizing the clinical relevance should be included.
STYLE AND FORMATTING
Page format: Submitted manuscripts should have at least a 1-inch (2.5-cm) margin on all sides. The manuscript should be double spaced, including legends, footnotes, tables, and references. If a structured abstract is required for your submission category, please ensure that the abstract is included within the manuscript Word file.
Title page: Include on the title page: a) complete manuscript title; b) authors' full names, highest academic degrees, and affiliations; c) name and address for correspondence, including fax number, telephone number, and e-mail address; d) acknowledgments.
The title page must also include disclosure of funding received for this work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s).
Acknowledgments: Acknowledge all forms of support, including pharmaceutical and industry support, in an Acknowledgments paragraph. As per the “Authorship Responsibility, Financial Disclosure, and Copyright Transfer”, all industry relationships must be clearly disclosed.
Style: Pattern manuscript style after the American Medical Association Manual of Style (9th edition). Stedman's Medical Dictionary (27th edition) and Merriam Webster's Collegiate Dictionary (10th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not use abbreviations. Use code numbers only when a generic name is not yet available. In that case, supply the chemical name and a figure giving the chemical structure of the drug. Capitalize the trade names of drugs and place them in parentheses after the generic names. To comply with trademark law, include the name and location (city and state in U.S.A.; city and country outside U.S.A.) of the manufacturer of any drug, supply, or equipment mentioned in the manuscript. Use the metric system to express units of measure and degrees Celsius to express temperatures, and use SI units rather than conventional units.
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. Write out the full term for each abbreviation at its first use, unless it is a standard unit of measure, and in each table and figure. If a brand name is cited, supply the manufacturer's name and address (city and state/country).
References: The authors are responsible for the accuracy of the references. Key the references (double spaced) at the end of the manuscript. They should be cited in the text in the order of appearance. Cite unpublished data, such as papers submitted but not yet accepted for publication or personal communications, in parentheses in the text. If there are more than three authors, name only the first three authors and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below:
1. Newcomer KL, Laskowski ER, Idank DM, et al. Corticosteroid injection in early treatment of lateral epicondylitis. Clin J Sport Med. 2001;11:214–222.
2. Claessens AL. Elite female gymnasts: a kinanthropometric over-view. In: Johnston FE, Eveleth P, Zemel B, eds. Human Growth in Context. London: Smith-Gordon and Co; 1999:273–280.
3. Stewart JD, ed. Focal Peripheral Neuropathies. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
4. Epi Info [computer program]. Version 6. Atlanta, GA: Centers for Disease Control and Prevention; 1994.
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22–37. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990.
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996.
World Wide Web
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997.
Tables: Create tables using the table creating and editing feature of your word processing software (eg, Word, WordPerfect). Do not use Excel or comparable spreadsheet programs. Group all tables at the end of the manuscript, or supply them together in a separate file. Cite tables consecutively in the text, and number them in that order. Key on a separate sheet, and include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). They should be self-explanatory and should supplement, rather than duplicate, the material in the text.
A) Creating Digital Artwork
Create, Scan and Save your artwork and compare your final figure to the Digital Artwork Guideline Checklist (below).
Upload each figure to Editorial Manager in conjunction with your manuscript text and tables.
B) Digital Artwork Guideline Checklist
Here are the basics to have in place before submitting your digital artwork:
Artwork should be saved as TIFF, EPS, or MS Office (DOC, PPT, XLS) files. High resolution PDF files are also acceptable.
Crop out any white or black space surrounding the image.
Diagrams, drawings, graphs, and other line art must be vector or saved at a resolution of at least 1200 dpi. If created in an MS Office program, send the native (DOC, PPT, XLS) file.
Photographs, radiographs and other halftone images must be saved at a resolution of at least 300 dpi.
Photographs and radiographs with text must be saved as postscript or at a resolution of at least 600 dpi.
Each figure must be saved and submitted as a separate file. Figures should not be embedded in the manuscript text file.
Cite figures consecutively in your manuscript.
Number figures in the figure legend in the order in which they are discussed.
Upload figures consecutively to the Editorial Manager web site and enter figure numbers consecutively in the Description field when uploading the files.
Figure legends: Legends must be submitted for all figures. They should be brief and specific, and they should appear on a separate manuscript page after the references. Use scale markers in the image for electron micrographs, and indicate the type of stain used.
Color figures: The journal accepts for publication color figures that will enhance an article. Authors who submit color figures will receive an estimate of the cost for color reproduction. If they decide not to pay for color reproduction, they can request that the figures be converted to black and white at no charge.
SUPPLEMENTAL DIGITAL CONTENT (SDC)
Authors may submit SDC via Editorial Manager to LWW journals that enhance their article's text to be considered for online posting. SDC may include standard media such as text documents, graphs, audio, video, etc. On the Attach Files page of the submission process, please select Supplemental Audio, Video, or Data for your uploaded file as the Submission Item. If an article with SDC is accepted, our production staff will create a URL with the SDC file. The URL will be placed in the call-out within the article. SDC files are not copy-edited by LWW staff, they will be presented digitally as submitted. For a list of all available file types and detailed instructions, please visit http://links.lww.com/A142.
Supplemental Digital Content must be cited consecutively in the text of the submitted manuscript. Citations should include the type of material submitted (Audio, Figure, Table, etc.), be clearly labeled as "Supplemental Digital Content," include the sequential list number, and provide a description of the supplemental content. All descriptive text should be included in the call-out as it will not appear elsewhere in the article.
We performed many tests on the degrees of flexibility in the elbow (see Video, Supplemental Digital Content 1, which demonstrates elbow flexibility) and found our results inconclusive.
List of Supplemental Digital Content
A listing of Supplemental Digital Content must be submitted at the end of the manuscript file. Include the SDC number and file type of the Supplemental Digital Content. This text will be removed by our production staff and not be published.
Supplemental Digital Content 1. wmv
SDC File Requirements
All acceptable file types are permissible up to 10 MBs. For audio or video files greater than 10 MBs, authors should first query the journal office for approval. For a list of all available file types and detailed instructions, please visit http://links.lww.com/A142.
Manuscripts returned to authors for revisions must be resubmitted (with revisions) within two months to be considered for publication. Revised manuscript submission must include: a cover letter, the revised manuscript, and a letter itemizing, point by point, the response to each one of the suggestions/criticisms raised by the referees, highlighting the response and revisions made to the manuscript, or providing justifiable rebuttal.
Page proofs and corrections: Corresponding authors will receive page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (e.g., reprint order form) will be sent to the corresponding author via e-mail. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing the corrected pages to the publisher. Those authors without an e-mail address will receive traditional page proofs. It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to Journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections faxed within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Reprints: Authors will receive a reprint order form and a price list with the page proofs. Reprint requests should be faxed with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 351 W. Camden Street, Baltimore, MD 21201; Fax: 410.528.4434; E-mail: firstname.lastname@example.org with any questions.
Publisher's contact: Fax corrected page proofs, reprint order forms, and any other related materials to Journal Production Editor, Clinical Journal of Sport Medicine, 410-558-6840.